BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 5394514)

  • 1. [Oral treatment of diabetes mellitus with the new sulfonylurea tolazamide].
    Vogel G; Krummel E
    Arzneimittelforschung; 1969 Jul; 19(7):1128-30. PubMed ID: 5394514
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of oral therapy of diabetes mellitus with the new sulfonylurea tolazamide under ambulatory conditions].
    Düntsch G
    Arzneimittelforschung; 1970 Apr; 20(4):577-9. PubMed ID: 5467825
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of oral therapy of diabetes mellitus with the new sulfonylurea tolazamide under ambulatory conditions].
    Düntsch G
    Arzneimittelforschung; 1970 Apr; 20(4):575-9. PubMed ID: 5467824
    [No Abstract]   [Full Text] [Related]  

  • 4. Tolazamide in the treatment of diabetes mellitus: clinical experience and review of the literature.
    Balodimos MC; Marble A
    Curr Ther Res Clin Exp; 1971 Jan; 13(1):6-12. PubMed ID: 4992570
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the clinical use of biguanides].
    Haese E
    Arzneimittelforschung; 1969 Apr; 19(4):633-8. PubMed ID: 5819164
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with sulfonylurea tolazamide in an out-patient clinic for diabetics].
    Kanzler G; Trenkner G; Rausch-Stroomann JB
    Arzneimittelforschung; 1968 Oct; 18(10):1345-8. PubMed ID: 5756166
    [No Abstract]   [Full Text] [Related]  

  • 7. [Oral antidiabetic monotherapy and combination treatment with glybenclamide (HB 419) and biguanides of insulin receiving diabetics of the adult type].
    Knick B; Wendt O; Konder ML; Netter P
    Med Klin; 1970 Jan; 65(3):109-12. PubMed ID: 5519048
    [No Abstract]   [Full Text] [Related]  

  • 8. [Behavior of serum insulin under the influence of glisoxepide with and without butylbiguanide].
    Birk W; Petrides P
    Arzneimittelforschung; 1974 Mar; 24(0):425-9. PubMed ID: 4408033
    [No Abstract]   [Full Text] [Related]  

  • 9. Biguanides. Mode of action and role in the up-to-date treatment of diabetes mellitus.
    Fövényi J
    Ther Hung; 1971; 19(2):43-8. PubMed ID: 5172874
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparision of chlorpropamide with tolazamide in the treatment of diabetes mellitus.
    Sherwood G; Bressler R
    Curr Ther Res Clin Exp; 1968 Aug; 10(8):399-405. PubMed ID: 4970053
    [No Abstract]   [Full Text] [Related]  

  • 11. [Application of the method of continuois recording of glycemia to the study of the action of hypoglycemic agents in the diabetic].
    Drouin P; Mejean L; Guisard D; Debry G
    Nutr Metab; 1974; 16(5):261-7. PubMed ID: 4836869
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus].
    Ninni M; Castelletta L
    Minerva Med; 1973 Oct; 64(71):3725-31. PubMed ID: 4588364
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin and oral hypoglycemic agents.
    Price MJ
    Nurs Clin North Am; 1983 Dec; 18(4):687-706. PubMed ID: 6359069
    [No Abstract]   [Full Text] [Related]  

  • 14. [Regadrin treatment of diabetes mellitus].
    Hohlfeld R; Neugebauer A; Haaser B; Marek H; Reuter W
    Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:154-6. PubMed ID: 4734038
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral management of uncomplicated maturity onset diabetes.
    Mashaly M; el-Ebrashy N; Higazi AM; Einen MA; Aziz MT
    J Egypt Med Assoc; 1974; 57(7-8):288-97. PubMed ID: 4217809
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the therapy of diabetes mellitus with biguanides].
    Riess PJ; Saum R
    Med Klin; 1968 May; 63(19):764-7. PubMed ID: 5730198
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of diabetes therapy with Silubin retard].
    Kopp H
    Med Klin; 1966 Apr; 61(15):592-6. PubMed ID: 4869026
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combined administration of insulin and oral agents].
    Tasaka H
    Nihon Rinsho; 1973 Jul; 31(7):2286-93. PubMed ID: 4795329
    [No Abstract]   [Full Text] [Related]  

  • 19. [Our experience with Daonil. A new oral hypoglycemic agent].
    Rodriguez-Miñon JL; Arrieta F; Herrera JL
    Diabete; 1970; 18(3):164-5. PubMed ID: 5472233
    [No Abstract]   [Full Text] [Related]  

  • 20. [Concepts on the management of diabetic patients].
    Zorrilla E; Chávez Domínguez R; Magos C; Serrano PA
    Arch Inst Cardiol Mex; 1971; 41(1):97-105. PubMed ID: 5001816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.